Revenge quitting: is it ever a good idea to leave your job in anger?

GaudiLab/ShutterstockMany of us will have experienced the rage that comes with being badly treated at work – and maybe even felt the instinct to pack up and leave. Bad bosses, belittling treatment or poor pay could be behind these kneejerk emotions. But, while most employees swallow their anger and get back to work, some walk out in a way that tells their employer exactly how they feel. Welcome to the world of “revenge quitting”.

IFDP Paper: The case for supporting liquidity supply in (some corners of) non-bank intermediation

Sirio AramonteAfter the Global Financial Crisis, the liquidity-supply ecosystem that underpins nonbank intermediation shifted away from traditional dealers. Instead, it started to rely more on intermediaries with fragile funding structures and opportunistic investment strategies. Over the years, stress episodes saw the sudden retrenchment of these intermediaries, which amplified liquidity imbalances and market malfunction.

IFDP Paper: Retail inventories and inflation dynamics: The price margin channel

Neil Mehrotra, Hyunseung Oh, and Julio L. OrtizUsing industry-level panel data and plausibly exogenous variation in supply conditions, we estimate the elasticity of retail price margins with respect to inventories along the retailer's optimal pricing curve. We find that this elasticity is negative and statistically significant, implying that lower finished-good inventories lead to higher price margins.

FEDS Paper: Decomposing Recent Employment Gains Among Disabled Workers

Hsinyu (Samuel) Tseng, Douglas A. WebberWe use the longitudinal component of the Current Population Survey to compare transition rates into and out of disability and employment prior to and after the onset of the pandemic. We find that one-third of the increased employment rate among disabled people is due to the excess incidence of disability seen following the pandemic, while the other two-thirds is attributable to higher participation among people whose disabilities were unrelated to the pandemic.

Drug Price Wars: What Can Really Tame Big Pharma?

Here’s the breakdown on what’s really driving America’s runaway drug prices -- and whether any of the current plans stand a chance to lower your pharmacy bill.
When it comes to the sickening cost of prescription drugs in America, this much is true: Big Pharma didn’t get rich by playing nice. It got rich playing Wall Street games.

For decades, economist William Lazonick has been exposing how Pharma’s Wall Street-driven business model doesn’t just lead to sky-high drug prices, but actually stifles innovation, too.

Pages

Subscribe to Front page feed